Cargando…

Targeting lymphatics in inflammatory bowel disease

Detalles Bibliográficos
Autores principales: D'Aiessio, Silvia, Tacconi, Carlotta, Danese, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741425/
https://www.ncbi.nlm.nih.gov/pubmed/26452136
_version_ 1782413988285382656
author D'Aiessio, Silvia
Tacconi, Carlotta
Danese, Silvio
author_facet D'Aiessio, Silvia
Tacconi, Carlotta
Danese, Silvio
author_sort D'Aiessio, Silvia
collection PubMed
description
format Online
Article
Text
id pubmed-4741425
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47414252016-03-15 Targeting lymphatics in inflammatory bowel disease D'Aiessio, Silvia Tacconi, Carlotta Danese, Silvio Oncotarget Editorial Impact Journals LLC 2015-10-07 /pmc/articles/PMC4741425/ /pubmed/26452136 Text en Copyright: © 2015 D'Aiessio et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
D'Aiessio, Silvia
Tacconi, Carlotta
Danese, Silvio
Targeting lymphatics in inflammatory bowel disease
title Targeting lymphatics in inflammatory bowel disease
title_full Targeting lymphatics in inflammatory bowel disease
title_fullStr Targeting lymphatics in inflammatory bowel disease
title_full_unstemmed Targeting lymphatics in inflammatory bowel disease
title_short Targeting lymphatics in inflammatory bowel disease
title_sort targeting lymphatics in inflammatory bowel disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741425/
https://www.ncbi.nlm.nih.gov/pubmed/26452136
work_keys_str_mv AT daiessiosilvia targetinglymphaticsininflammatoryboweldisease
AT tacconicarlotta targetinglymphaticsininflammatoryboweldisease
AT danesesilvio targetinglymphaticsininflammatoryboweldisease